| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.10.23 | Actinogen Medical - Taking steps to mitigate funding headwinds | 400 | Edison Investment Research | Actinogen is refining the design of its XanaMIA Phase IIb study of lead candidate Xanamem in patients with cognitive impairment (CI) associated with mild-to-moderate Alzheimer's disease (AD). The study... ► Artikel lesen | |
| 25.10.23 | Endeavour Mining - Leaner and ready to grow | 433 | Edison Investment Research | In the wake of the release of Edison's updated long-term gold price assumptions (Shades of the 1970s), we have amended our forecasts for Endeavour, prior to the release of its Q323 results on 9 November.... ► Artikel lesen | |
| 25.10.23 | abrdn Private Equity Opportunities Trust - Resilient NAV and stable balance sheet | 336 | Edison Investment Research | abrdn Private Equity Opportunities Trust (APEO) posted a 12-month NAV TR of 5.1% to end-September 2023 amid persistently muted exit activity across PE markets and FX headwinds from stronger sterling.... ► Artikel lesen | |
| 25.10.23 | paragon - A dip in the road ahead | 445 | Edison Investment Research | paragon expects extended summer breaks and anticipated year-end shutdowns of customer plants to restrict growth in H223. We have reduced our earnings expectations to reflect the disposal of the battery... ► Artikel lesen | |
| 25.10.23 | BB Biotech - A cutting-edge sector and a high dividend | 1.625 | Edison Investment Research | BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. BION is the largest biotech investor among its investment company peers. It invests in high-quality biotech... ► Artikel lesen | |
| 25.10.23 | Paradigm Biopharma - Disease modifying properties in iPPS Phase II | 211 | Edison Investment Research | Paradigm reported favourable quantitative MRI data from the six-month analysis of the Phase II trial (PARA OA 008) evaluating a single six-week course of injectable pentosan polysulfate sodium (iPPS)... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.512 |
| NEL | 1.013 |
| BAYER | 899 |
| TUI | 729 |
| BYD | 658 |
| DEUTSCHE BANK | 634 |
| RWE | 581 |
| MERCEDES-BENZ | 576 |
| NVIDIA | 554 |
| RHEINMETALL | 514 |
| PLUG POWER | 491 |
| SUPER MICRO COMPUTER | 477 |
| TESLA | 453 |
| DEUTSCHE LUFTHANSA | 420 |
| AIXTRON SE | 417 |
| BIONTECH | 415 |
| VOLKSWAGEN | 392 |
| RENK GROUP | 379 |
| COMMERZBANK | 363 |
| ALLIANZ | 359 |
| PALANTIR TECHNOLOGIES | 358 |
| SIEMENS ENERGY | 354 |
| THYSSENKRUPP | 344 |
| BASF | 343 |
| VARTA | 339 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
